786-O/Cre cells are derived from the human renal cell carcinoma 786-O cell line by stably integration of a constitutive Cre recombinase stably expression construct. The 786-O cell line has been widely used in cancer research and drug development. 786-O /Cre cells stably express a nuclear localized Cre recombinase.